Historique
Rapport
Medications for opioid use disorder. For healthcare and addiction professionals, policymakers, patients, and families
Auteur(s) :
SAMHSA (Substance Abuse and Mental Health Services Administration)
Année
2020
Page(s) :
332 p.
Langue(s) :
Anglais
Éditeur(s) :
Rockville, MD : SAMHSA
, Publication No. PEP20-02-01-006
Collection :
Treatment Improvement Protocol (TIP), 63
Domaine :
Autres substances / Other substances ; Drogues illicites / Illicit drugs
Thésaurus mots-clés
DONNEE PROBANTE
;
TRAITEMENT
;
PHARMACOTHERAPIE
;
TRAITEMENT DE MAINTENANCE
;
PHARMACOLOGIE
;
METHODE
;
ORIENTATION
;
DEPISTAGE
;
OPIOIDES
;
HEROINE
;
FENTANYL
;
MEDECIN GENERALISTE
;
PERSONNEL MEDICAL
;
BUPRENORPHINE
;
METHADONE
;
NALTREXONE
Thésaurus géographique
ETATS-UNIS
Résumé :
The goal of treatment for opioid addiction or opioid use disorder (OUD) is remission of the disorder leading to lasting recovery. Recovery is a process of change through which individuals improve their health and wellness, live self-directed lives, and strive to reach their full potential. This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD - methadone, naltrexone, and buprenorphine - and the other strategies and services needed to support recovery for people with OUD.
Affiliation :
USA
Autre(s) lien(s) :
Executive summary (16 p.)